(Q73069266)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

antiphospholipid syndrome

1 November 2019

main subject

1 reference

S Welsch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D W Branch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

Rheumatic Diseases Clinics of North America

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

71-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

Sixty-six cases of intrauterine fetal death. A prospective study with an extensive test protocol

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies and risk of intrauterine late fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Obstetric complications associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies and cerebral ischemia in young people

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Interlaboratory inconsistencies in detection of anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Lupus anticoagulant and the fibrinolytic system in young patients with stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Histological classification of tissue from spontaneous abortions: a valueless exercise?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Thrombotic skin disease as a marker of the anticardiolipin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Syndrome of the black swan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Cerebral infarction associated with lupus anticoagulants--preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Answers to the antiphospholipid-antibody syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Binding specificity of lupus anticoagulants and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Intrauterine death and circulating anticoagulant ("antithromboplastin")

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies and fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Prevalence of antiphospholipid antibodies in patients with fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies in pregnancy: prevalence and clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Interlaboratory variation in antiphospholipid antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Are immunoglobulins with lupus anticoagulant activity specific for phospholipids?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Etiologic factors of recurrent abortion and subsequent reproductive performance of couples: have we made any progress in the past 10 years?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Recurrent adverse pregnancy outcome and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Anti-cardiolipin antibodies and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Anticardiolipin antibodies: clinical consequences of "low titers"

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibodies in pre‐eclamptic women: Relation to growth retardation and neonatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Mechanism of recurrent spontaneous abortion. I. Ultrasonographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

First-trimester ultrasonography findings in women with a history of recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970315-X

7 January 2021

10.1016/S0889-857X(05)70315-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9031375%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference